Nemocnice T.Bati, Zlin Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2016
NCT02956057
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Nemocnice AGEL Trinec-Podlesi a.s. | Nemocnice T.Bati

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Inflammatory Bowel Diseases (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 5